Table IV.
KEGG pathways analysis of differentially expressed genes.
| Term | Count | P-value | Genes | Up | Down |
|---|---|---|---|---|---|
| Glutathione metabolism | 1 | 0.106032 | Gsta2 | 0 | 1 |
| Metabolism of xenobiotics by cytochrome P450 | 1 | 0.143567 | Gsta2 | 0 | 1 |
| Drug metabolism-cytochrome P450 | 1 | 0.147434 | Gsta2 | 0 | 1 |
| Ribosome | 1 | 0.172182 | Rps3a | 0 | 1 |
| PPAR signaling pathway | 1 | 0.143567 | Adipoq | 0 | 1 |
| Calcium signaling pathway | 3 | 0.00614 | P2rx7, Ptger1, Ptafr | 3 | 0 |
| Cytokine-cytokine receptor interaction | 1 | 0.45143 | Cxcl1 | 0 | 1 |
| Chemokine signaling pathway | 1 | 0.353888 | Cxcl1 | 0 | 1 |
| Neuroactive ligand-receptor interaction | 4 | 0.001745 | P2rx7, Ptger1, Ptafr, Vipr1 | 4 | 0 |
| Cell cycle | 1 | 0.226819 | Hdac1 | 0 | 1 |
| Apoptosis | 1 | 0.179664 | Prkar2b | 1 | 0 |
| Notch signaling pathway | 1 | 0.099971 | Hdac1 | 0 | 1 |
| Insulin signaling pathway | 1 | 0.268146 | Prkar2b | 1 | 0 |
| Adipocytokine signaling pathway | 1 | 0.139685 | Adipoq | 0 | 1 |
| Type II diabetes mellitus | 1 | 0.099971 | Adipoq | 0 | 1 |
| Huntington's disease | 1 | 0.334126 | Hdac1 | 0 | 1 |
| Pathways in cancer | 1 | 0.530933 | Hdac1 | 0 | 1 |
| Chronic myeloid leukemia | 1 | 0.155119 | Hdac1 | 0 | 1 |